XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Product Information [Line Items]          
Cash FDIC insurance $ 250,000   $ 250,000   $ 500,000
Patent and licensing legal and filing fees and costs $ 271,163 $ 137,114 $ 944,789 $ 365,466  
Revenue Benchmark [Member] | Product Concentration Risk [Member] | General and Administrative Expense [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 22.50% 13.60% 25.00% 9.70%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor One [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 32.00% 13.50% 31.00% 33.20%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Two [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 23.20% 13.20% 16.70% 26.90%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Three [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 16.90% 12.70%   10.50%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Four [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 11.00%